Amarantus to Present at the LD Micro Main Event VII Investor Conference on December 2, 2014
8:00 AM ET, 11/24/2014 - GlobeNewswire

SAN FRANCISCO and GENEVA, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a diversified biotechnology company focused on the development of diagnostic and therapeutic products in the areas of neurology, psychiatry, ophthalmology and regenerative medicine announced today that Gerald E. Commissiong, President and Chief Executive Officer, will present at the LD Micro Main Event VII micro-cap investor conference being held December 2 - 4, 2014 at the Luxe Sunset Hotel in Los Angeles, California.

Mr. Commissiong will present on Tuesday, December 2, 2014 at 10:30 a.m. PST (1:30 p.m. EST) and will provide an update on Amarantus' recent corporate milestone achievements, clinical development progress and expected near-term catalysts.

A live audio webcast of the presentation may be accessed via the News and Events page of the Investor Relations section of the Amarantus corporate web site under the IR Calendar at www.amarantus.com. A replay of the webcast will be available approximately two hours after the presentation ends and will be archived for 30 days.

Investors attending the conference may schedule one-on-one meetings with Mr. Commissiong in advance or onsite directly through LD Micro.